×
戻る Agenda
Part 2: Signaling Approaches/Methods
Session Chair(s)
James Buchanan, PHARMD
President
Covilance LLC, United States
- Analysis of Post-Marketing Data
- Comparison to Clinical Trial Data
- Signaling Examples
- Case Studies